These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 11922858)
41. Dopamine agonists. Factor SA Med Clin North Am; 1999 Mar; 83(2):415-43, vi-vii. PubMed ID: 10093586 [TBL] [Abstract][Full Text] [Related]
42. [The relevance of dopamine agonists in the treatment of depression]. Clausius N; Born C; Grunze H Neuropsychiatr; 2009; 23(1):15-25. PubMed ID: 19272288 [TBL] [Abstract][Full Text] [Related]
43. [Principles of the pharmacological treatment of drug addiction]. Saadan M; Scuvée-Moreau J; Seutin V Rev Med Liege; 2013; 68(5-6):245-51. PubMed ID: 23888572 [TBL] [Abstract][Full Text] [Related]
44. Bromocriptine-desipramine protocol in treatment of cocaine addiction. Giannini AJ; Billett W J Clin Pharmacol; 1987 Aug; 27(8):549-54. PubMed ID: 3308977 [TBL] [Abstract][Full Text] [Related]
45. Norepinephrine and stimulant addiction. Sofuoglu M; Sewell RA Addict Biol; 2009 Apr; 14(2):119-29. PubMed ID: 18811678 [TBL] [Abstract][Full Text] [Related]
46. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Benowitz NL Annu Rev Pharmacol Toxicol; 2009; 49():57-71. PubMed ID: 18834313 [TBL] [Abstract][Full Text] [Related]
47. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats. Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384 [TBL] [Abstract][Full Text] [Related]
48. New horizons for therapeutics in drug and alcohol abuse. Jupp B; Lawrence AJ Pharmacol Ther; 2010 Jan; 125(1):138-68. PubMed ID: 19917308 [TBL] [Abstract][Full Text] [Related]
49. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. Gyertyán I; Gál K Neuroreport; 2003 Jan; 14(1):93-8. PubMed ID: 12544838 [TBL] [Abstract][Full Text] [Related]
50. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease. Linazasoro G; J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015 [TBL] [Abstract][Full Text] [Related]
51. Treatment of cocaine abuse: pharmacotherapy. Kleber HD Ciba Found Symp; 1992; 166():195-200; discussion 200-6. PubMed ID: 1638913 [TBL] [Abstract][Full Text] [Related]
52. Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature. Thobois S Clin Ther; 2006 Jan; 28(1):1-12. PubMed ID: 16490575 [TBL] [Abstract][Full Text] [Related]
53. Drug abuse and therapy. McMillen BA Science; 1998 Jan; 279(5348):159-61. PubMed ID: 9446217 [No Abstract] [Full Text] [Related]